FDA Inspection
Janaki (NMI) Nadarajah DPMJanaki (NMI) Nadarajah DPM – FDA Inspection, Mar 7, 2024
Record Details
This FDA Inspection record concerns Janaki (NMI) Nadarajah DPM, with an inspection on March 7, 2024, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · 304a10e6-2229-484a-95c5-59c1dae760b0
Inspection Facts
- Inspection number
- 1234038
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(a)Accountability records
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Janaki (NMI) Nadarajah DPM
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 4, 2016 | VAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Janaki (NMI) Nadarajah DPM
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.